Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

390 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-01-31

Study Completion Date

2004-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Overall improvement, severities and changes of specific clinical symptoms were surveyed in outpatients with depression or in a depressed state to evaluate the efficacy and safety of PAXIL tablets in patients in whom the PAXIL dose was increased and those treated with a constant dose.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Drug Use Investigation for PAXIL Tablet

NCT01371435

Mental Disorders

COMPLETED

Special Drug Use Investigation for PAXIL Tablet (Long-term)

NCT01371448

Mental Disorders

COMPLETED

Combination Of PAXIL Tablet And Benzodiazepines

NCT00259883

Mental Disorders

COMPLETED PHASE4

MDD POC Study GSK372475 Subjects Depressive Disease

NCT00420641

Depressive Disorder

COMPLETED PHASE2

A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

NCT00048204

Depressive Disorder, Major

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mental Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients prescribed PAXIL

Patients with depression or depressed state prescribed PAXIL during study period

Paroxetine

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Paroxetine

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects who is 18 years or more
* Subjects diagnosed with depression or in a depressed state

Exclusion Criteria

* Subjects who have been treated with paroxetine prior to this investigation
* Subjects with hypersensitivity to paroxetine
* Subjects taking monoamine oxidase inhibitors (MAOIs) or within 2 weeks of stopping treatment with MAOIs
* Concomitant use in subjects taking pimozide

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No